Concepedia

Simeng Wang

SW

Statistics

Publications

2

Citations

22

H-Index

2

Active since

2024

Affiliations

Shenyang Pharmaceutical University(Current)

Simeng Wang is an author at Shenyang Pharmaceutical University specializing in glycolysis, cdkn2a deletion, and tumor immune microenvironment.

ORCID

Publications per year

2024–2024

2

Publications

2

The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor

Yuan Yang, Zefei Li, Yidong Wang et al. · EMBO Molecular Medicine · 2024 · 11 citations · Full text

, , +17

Loss of <i>CDKN2A</i> Enhances the Efficacy of Immunotherapy in <i>EGFR</i> -Mutant Non–Small Cell Lung Cancer

Simeng Wang, Jia-Cheng Lai, Chengfang Tang et al. · Cancer Research · 2024 · 11 citations

, , +17

1–2 of 2